3 ASX 200 shares tipped to rise 20% or more

These ASX 200 stocks remain undervalued.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors often target blue-chip ASX 200 shares for lower volatility and consistent earnings. 

It's often assumed that because these companies are well-established, there is limited upside. 

However, here are some blue-chip stocks that have recently received price targets from brokers indicating upside of 20% or more. 

A senior couple discusses a share trade they are making on a laptop computer.

Image source: Getty Images

Qantas Airways Ltd (ASX: QAN)

With oil prices skyrocketing and geopolitical tension impacting global travel, Qantas shares have faced some volatility recently. 

The company noted that it is facing uncertainty due to Middle East tensions and rising jet fuel refining margins. 

However, it has hedged crude oil exposure and remains confident in fuel supply through April and May. 

Strong international demand – especially to Europe – has led the airline to redeploy aircraft and cut domestic capacity, with higher airfares expected to lift unit revenue by about 5% in the second half of FY26.

These headwinds have pushed its stock price down by 12% year to date. 

In good news for prospective buyers, the Qantas share price could now be a significant value. 

Macquarie recently placed a $11 price target on the airline's shares, which would be a 20% rise from the share price at the time of writing. 

As a bonus, experts are tipping a healthy dividend yield for the ASX 200 company throughout the next few years. 

Telix Pharmaceuticals Ltd (ASX: TLX)

Like many ASX 200 healthcare shares, the Telix stock price has fallen heavily in the last 12 months. 

However, the commercial-stage biopharmaceutical company has rebounded significantly over the past month. 

Brokers believe this could be the start of a longer rally. 

Recently, Bell Potter placed a buy rating and $19 price target on Telix shares after the company announced the refinancing of its convertible note facility. 

The share price at the time of writing is hovering around $14.59, which indicates an upside potential of 30%. 

Life360 Inc (ASX: 360)

Despite now climbing 26% over the last 6 days at the time of writing, the Life360 share price remains significantly below its yearly highs. 

The company's core product is a private family and friends social networking app that allows users to communicate and share their locations.

At the time of writing, this ASX 200 stock is exchanging hands for $22.72 per share. 

However, this is significantly below the $36.02 average price targets of 10 analysts via TradingView. 

Should this ASX 200 stock reach that level in the next 12 months, it would be a 58% rise from current levels. 

Motley Fool contributor Aaron Bell has positions in Telix Pharmaceuticals. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Life360, Macquarie Group, and Telix Pharmaceuticals. The Motley Fool Australia has positions in and has recommended Life360 and Macquarie Group. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

Broker reiterates buy ratings on 2 ASX shares

These ASX shares remain worth watching.

Read more »

Sell buy and hold on a digital screen with a man pointing at the sell square.
Broker Notes

After more than quadrupling investors' money in a year, are PLS shares still a buy?

A leading analyst delivers his outlook for the soaring PLS share price.

Read more »

A young man wearing a bright yellow jumper and glasses purses his lips together and moves them to the side of his face as he wonders about something.
Broker Notes

Buy, hold, or sell? Life360, Iress, Lynas Rare Earths shares

Experts reveal their views.

Read more »

Worried woman calculating domestic bills.
Broker Notes

Why did this broker just lower its outlook on this ASX 200 stock?

Despite a lowered outlook, attractive upside remains.

Read more »

Three climbers scramble up a rocky peak overlooking a vast snow covered mountain range with an icy blue sky beyond them.
52-Week Highs

What are experts saying about these red hot ASX 200 shares?

These stocks are soaring right now.

Read more »

Shocked office worker staring at computer screen with colleagues working in the background.
Broker Notes

Buy, hold, sell: Cleanaway, Hub24, and MAAS shares

Morgans has given its verdict on these shares. Is it bullish or bearish? Let's find out.

Read more »

Three excited business people cheer around a laptop in the office
Broker Notes

Missed out on Hub24 and Netwealth? Bell Potter thinks this ASX tech stock is next

This small-cap could have major upside potential according to the broker.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Broker Notes

Buy this ASX defence stock with a 'high ROIC business model'

Bell Potter has good things to say about this exciting company.

Read more »